Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABCG2 | Q9UNQ0 | 13/20 | 0.46 |
| ▸ | ABCB1 | P08183 | 8/20 | 0.46 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.42 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.42 |
| ▸ | ABCC1 | P33527 | 3/20 | 0.41 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.41 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.41 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.41 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.41 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.41 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.41 |
| ▸ | PGR | P06401 | 1/20 | 0.41 |
| ▸ | MYC | P01106 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21395808 | 0.99 | ABCG2 (0.45) | ABCG2ABCB1PIK3CDPIK3CAABCC1 | |
| SCHEMBL15305785 | 0.97 | ABCG2 (0.46) | ABCG2ABCB1PIK3CDPIK3CAABCC1 | |
| SCHEMBL21395873 | 0.96 | ABCG2 (0.43) | ABCG2ABCB1PIK3CDPIK3CAABCC1 | |
| SCHEMBL16809863 | 0.96 | ABCG2 (0.42) | ABCG2ABCB1PIK3CDPIK3CAABCC1 | |
| SCHEMBL16809537 | 0.96 | ABCG2 (0.42) | ABCG2ABCB1PIK3CDPIK3CAABCC1 | |
| SCHEMBL21396063 | 0.95 | ABCG2 (0.42) | ABCG2ABCB1PIK3CDPIK3CAABCC1 | |
| SCHEMBL21395907 | 0.94 | ABCG2 (0.41) | ABCG2ABCB1PIK3CDPIK3CAABCC1 | |
| SCHEMBL17897500 | 0.94 | KDM4E (0.44) | ABCG2ABCB1PIK3CDPIK3CAABCC1 | |
| SCHEMBL16809607 | 0.94 | CYP1A2 (0.43) | ABCG2ABCB1PIK3CDPIK3CAABCC1 | |
| SCHEMBL21215262 | 0.92 | ABCG2 (0.44) | ABCG2ABCB1PIK3CDPIK3CAABCC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190292169-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190292169-A1 | HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | LAGE3, PPOX, SUN2 | ABCG2 2985/4885ABCB1 2827/4885PIK3CD 4712/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.